Biology Reference
In-Depth Information
[40] Seemayer TA, Lapp WS, Bolande RP. Thymic epithelial injury in graft-versus-host
reactions following adrenalectomy. Am J Pathol 1978;93(2):325-38. Epub 1978/11/01.
[41] Seemayer TA, Lapp WS, Bolande RP. Thymic involution in murine graft-versus-
host reaction. Epithelial injury mimicking human thymic dysplasia. Am J Pathol
1977;88(1):119-34. Epub 1977/07/01.
[42] Beschorner WE, Hutchins GM, Elfenbein GJ, Santos GW. The thymus in patients with
allogeneic bone marrow transplants. Am J Pathol 1978;92(1):173-86. Epub 1978/07/01.
[43] Krenger W, Rossi S, Hollander GA. Apoptosis of thymocytes during acute graft-versus-
host disease is independent of glucocorticoids. Transplantation 2000;69(10):2190-3.
Epub 2000/06/14.
[44] Krenger W, Rossi S, Piali L, Hollander GA. Thymic atrophy in murine acute graft-versus-
host disease is effected by impaired cell cycle progression of host pro-T and pre-T cells.
Blood 2000;96(1):347-54. Epub 2000/07/13.
[45] Na IK, Lu SX, Yim NL, Goldberg GL, Tsai J, Rao U, et al. The cytolytic molecules Fas
ligand and TRAIL are required for murine thymic graft-versus-host disease. J Clin
Invest120(1):343-56. Epub 2009/12/04.
[46] Shono Y, Ueha S, Wang Y, Abe J, Kurachi M, Matsuno Y, et al. Bone marrow graft-
versus-host disease: early destruction of hematopoietic niche after MHC-mismatched
hematopoietic stem cell transplantation. Blood 2010;115(26):5401-11. Epub
2010/04/01.
[47] Maury S, Mary JY, Rabian C, Schwarzinger M, Toubert A, Scieux C, et al. Prolonged
immune deficiency following allogeneic stem cell transplantation: risk factors and
complications in adult patients. Br J Haematol 2001;115(3):630-41.
[48] Teshima T, Reddy P, Liu C, Williams D, Cooke KR, Ferrara JL. Impaired thymic negative
selection causes autoimmune graft-versus-host disease. Blood 2003;102(2):429-35.
Epub 2003/03/29.
[49] van den Brink MR, Moore E, Ferrara JL, Burakoff SJ. Graft-versus-host-disease-associ-
ated thymic damage results in the appearance of T cell clones with anti-host reactivity.
Transplantation 2000;69(3):446-9. Epub 2000/03/08.
[50] Hollander GA, Widmer B, Burakoff SJ. Loss of normal thymic repertoire selection and
persistence of autoreactive T cells in graft vs host disease. J Immunol 1994;152(4):1609-
17. Epub 1994/02/15.
[51] Sakata T, Iwagami S, Tsuruta Y, Teraoka H, Tatsumi Y, Kita Y, et al. Constitutive expres-
sion of interleukin-7 mRNA and production of IL-7 by a cloned murine thymic stromal
cell line. J Leukoc Biol 1990;48(3):205-12.
[52] Heufler C, Topar G, Grasseger A, Stanzl U, Koch F, Romani N, et al. Interleukin 7 is pro-
duced by murine and human keratinocytes. J Exp Med 1993;178(3):1109-14.
[53] Madrigal-Estebas L, McManus R, Byrne B, Lynch S, Doherty DG, Kelleher D, et al.
Human small intestinal epithelial cells secrete interleukin-7 and differentially express
two different interleukin-7 mRNA transcripts: implications for extrathymic T-cell dif-
ferentiation. Hum Immunol 1997;58(2):83-90.
[54] Fry TJ, Mackall CL. Interleukin-7: from bench to clinic. Blood 2002;99(11):3892-904.
[55] Peschon JJ, Morrissey PJ, Grabstein KH, Ramsdell FJ, Maraskovsky E, Gliniak BC, et al.
Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient
mice. J Exp Med 1994;180(5):1955-60.
[56] Maeurer MJ, Lotze MT. Interleukin-7 (IL-7) knockout mice. Implications for lympho-
poiesis and organ-specific immunity. Int Rev Immunol 1998;16(3-4):309-22.
[57] Puel A, Ziegler SF, Buckley RH, Leonard WJ. Defective IL7R expression in T(-)B(+)NK(+)
severe combined immunodeficiency. Nat Genet 1998;20(4):394-7.
[58] Bolotin E, Annett G, Parkman R, Weinberg K. Serum levels of IL-7 in bone marrow
transplant recipients: relationship to clinical characteristics and lymphocyte count.
Bone Marrow Transplant 1999;23(8):783-8.
[59] Napolitano LA, Grant RM, Deeks SG, Schmidt D, De Rosa SC, Herzenberg LA, et al.
Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implica-
tions for T-cell homeostasis. Nat Med 2001;7(1):73-9.
[60] Fry TJ, Connick E, Falloon J, Lederman MM, Liewehr DJ, Spritzler J, et al. A potential
role for interleukin-7 in T-cell homeostasis. Blood 2001;97(10):2983-90.
[61] Maraskovsky E, O'Reilly LA, Teepe M, Corcoran LM, Peschon JJ, Strasser A. Bcl-2 can
rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in
mutant rag-1−/− mice. Cell. 1997;89(7):1011-9.
[62] Watson JD, Morrissey PJ, Namen AE, Conlon PJ, Widmer MB. Effect of IL-7 on the
growth of fetal thymocytes in culture. J Immunol 1989;143(4):1215-22.
[63] Candeias S, Muegge K, Durum SK. IL-7 receptor and VDJ recombination: trophic versus
mechanistic actions. Immunity 1997;6(5):501-8.
[64] He YW, Malek TR. Interleukin-7 receptor alpha is essential for the development of
gamma delta + T cells, but not natural killer cells. J Exp Med 1996;184(1):289-93.
136
Search WWH ::
Custom Search